Concepedia

Michel Weïwer

MW

Statistics

Publications

27

Citations

1.8K

H-Index

23

Active since

2005

Affiliations

Broad Institute(Current)

Harvard University

Rensselaer Polytechnic Institute

Centre National de la Recherche Scientifique

Howard Hughes Medical Institute

Michel Weïwer is an author at Broad Institute specializing in enzyme inhibition, drug discovery, and pharmacology.

Publications per year

2005–2022

27

Publications

27

Development of small-molecule probes that selectively kill cells induced to express mutant RAS

Michel Weïwer, Joshua A. Bittker, Timothy A. Lewis et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 238 citations

Medicine, Molecular Biology, Oncology +13

Chemoenzymatic Design of Heparan Sulfate Oligosaccharides*

Renpeng Liu, Yongmei Xu, Miao Chen et al. · Journal of Biological Chemistry · 2010 · 157 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +16

A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells

Michel Weïwer, James Spoonamore, Jingqiang Wei et al. · ACS Medicinal Chemistry Letters · 2012 · 147 citations · Full text

Medicine, Oncology, Pharmacology +15

Potent and Selective Inhibition of Histone Deacetylase 6 (HDAC6) Does Not Require a Surface-Binding Motif

Florence F. Wagner, David E. Olson, Jennifer Gale et al. · Journal of Medicinal Chemistry · 2013 · 122 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Kinetically selective inhibitors of histone deacetylase 2 (HDAC2) as cognition enhancers

Florence F. Wagner, Yarong Zhang, Daniel M. Fass et al. · Chemical Science · 2014 · 100 citations · Full text

Medicine, Neuroscience, Pharmacology +17

1–5 of 27